🇺🇸 Polygynax combinaison of polymyxin, Neomycin and Nystatin in United States

Polygynax combinaison of polymyxin, Neomycin and Nystatin (Polygynax combinaison of polymyxin, Neomycin and Nystatin) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Polygynax combinaison of polymyxin, Neomycin and Nystatin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Polygynax combinaison of polymyxin, Neomycin and Nystatin approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Polygynax combinaison of polymyxin, Neomycin and Nystatin in United States?

Laboratoire Innotech International is the originator. The local marketing authorisation holder may differ — check the official source linked above.